Thu, March 30, 2023
Wed, March 29, 2023
Tue, March 28, 2023
Mon, March 27, 2023
Fri, March 24, 2023
Thu, March 23, 2023
Wed, March 22, 2023

Reni Benjamin Maintained (BCAB) at Buy with Decreased Target to $12 on, Mar 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-12-on-mar-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Reni Benjamin of JMP Securities, Maintained "BioAtla, Inc." (BCAB) at Buy with Decreased Target from $17 to $12 on, Mar 27th, 2023.

Reni has made no other calls on BCAB in the last 4 months.



There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Reiterated at Hold and Held Target at $8 on, Friday, March 24th, 2023


These are the ratings of the 2 analyists that currently disagree with Reni


  • Arthur He of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 24th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Friday, March 24th, 2023

Publication Contributing Sources